-
Rip-offs at the petrol pump?
-
Shakira to wrap up world tour with Madrid residency
-
World gave Israel 'licence to torture Palestinians': UN expert
-
Colombia says 80 troops on crashed aircraft, many feared dead
-
France turns to 2027 race to succeed Macron
-
New Mercedes GLC electric
-
Namibia rejects Starlink licence request
-
Ex-model questioned in France over scout with Epstein links
-
UK sending air defence systems to Gulf: PM
-
Trump administration seeks to ease oil fears but industry wary
-
Blow to Italy's Meloni as she suffers referendum defeat
-
US deploys immigration agents to airports amid shutdown chaos
-
US, TotalEnergies reach 'nearly $1 bn' deal to end offshore wind projects
-
Spurs offer condolences to interim boss Tudor after father's death
-
Iran's true casualty figures unknown as internet blackout hampers monitors
-
Trump's ever-shifting positions on the war with Iran
-
Countries act to limit fuel price rise, cut consumption
-
'Stop, truck one, stop!': transcript of NY plane collision
-
Swiatek splits with coach Fissette after early Miami exit
-
WHO chief urges countries to complete pandemic agreement
-
Trump calls off Iran strikes and announces 'very good' talks
-
Russia, Vietnam advance plans for first nuclear power plant
-
New Trump envoy visits Honduras for organized crime-fighting partnership
-
No 'silver bullet' for video game age restrictions: PEGI chief
-
England coach McCullum survives review into Ashes drubbing
-
Mixed results for Lyme disease vaccine hit Valneva shares
-
Far-right French president no certainty despite rise of extremes
-
Trump tells AFP 'things are going very well' on Iran
-
Ukraine hits major Russian oil port near Finland
-
EU chief in Australia as trade talks enter 'last mile'
-
UK police probe attack on Jewish ambulances
-
Oil prices slide, European stocks rebound on Trump's Iran remarks
-
Trump announces 'very good' talks with Iran on ending war
-
Arsenal's White gets first England call-up since 2022
-
Greece train tragedy trial adjourned amid courtroom chaos
-
Tottenham face key call as relegation threat grows
-
German court rejects landmark climate case against BMW, Mercedes
-
Trump lifts Iran threat after 'very good' talks on ending war
-
Iran defies Trump Hormuz ultimatum with naval mine threat
-
African players in Europe: Awoniyi seals key win for lowly Forest
-
France ex-PM Lionel Jospin dies aged 88
-
Runway collision kills two pilots, shutters New York airport
-
Hodgkinson in 'shape of her life' with eye on Kratochvilova's record
-
Griezmann given go-ahead to talk with Orlando City
-
Mideast war threatens energy crisis worse than 1970s oil shocks
-
Pilot, co-pilot killed in runway collision at New York airport
-
Plane, fire truck collide on runway at New York's LaGuardia Airport
-
Russia's Max: The unencrypted super-app being forced on citizens
-
EU chief in Australia with eyes on trade deal
-
Asia champions Japan need 'different tools' to win World Cup - coach
Zuckerbergs put AI at heart of pledge to cure diseases
The Chan Zuckerberg Initiative, a nonprofit launched by Mark Zuckerberg and his wife aimed at curing all disease, on Thursday announced it was restructuring to focus its efforts on using artificial intelligence to achieve that goal.
The philanthropic mission created in 2016 by the Meta co-founder and his spouse, Priscilla Chan, said that its scientific teams will now be centralized in an organization dubbed Biohub.
"This is a pivotal moment in science, and the future of AI-powered scientific discovery is starting to come into view," Biohub said in a blog post.
"We believe that it will be possible in the next few years to create powerful AI systems that can reason about and represent biology to accelerate science."
Biohub envisions AI helping advance ways to detect, prevent and cure diseases, according to the post.
The mission includes trying to model the human immune system, potentially opening a door to "engineering human health."
"We believe we're on the cusp of a scientific revolution in biology -- as frontier artificial intelligence and virtual biology give scientists new tools to understand life at a fundamental level," Biohub said in the post.
The first investment announced by the Zuckerbergs when the initiative debuted was for the creation of a Biohub in San Francisco where researchers, scientists and others could work to build tools to better study and understand diseases.
Shortly after it was established, the initiative bought a Canadian startup which uses AI to quickly read and comprehend scientific papers and then provide insights to researchers.
"Our multidisciplinary teams of scientists and engineers have built incredible technologies to observe, measure and program biology," Biohub said of its progress.
Meta is among the big tech firms that have been pouring billions of dollars into data centers and more in a race to lead the field of AI.
V.Dantas--PC